| Literature DB >> 26670296 |
Susan W Law1, Steven R Levine1.
Abstract
In Europe, use of intravenous tissue plasminogen activator (tPA) in patients older than 80 years is discouraged because these patients have been excluded from certain past clinical trials. A new retrospective, observational study shows that tPA can substantially improve functional outcome after ischaemic stroke in patients aged 80–89 years.Entities:
Mesh：
Substances：
Year: 2015 PMID： 26670296 DOI： 10.1038/nrneurol.2015.231
Source DB: PubMed Journal: Nat Rev Neurol ISSN： 1759-4758 Impact factor: 42.937